Matches in Wikidata for { <http://www.wikidata.org/entity/Q67129705> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q67129705 description "clinical trial" @default.
- Q67129705 description "ensayu clínicu" @default.
- Q67129705 description "klinisch onderzoek" @default.
- Q67129705 description "клінічне випробування" @default.
- Q67129705 description "կլինիկական փորձարկում" @default.
- Q67129705 name "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor" @default.
- Q67129705 name "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor" @default.
- Q67129705 type Item @default.
- Q67129705 label "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor" @default.
- Q67129705 label "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor" @default.
- Q67129705 prefLabel "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor" @default.
- Q67129705 prefLabel "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor" @default.
- Q67129705 P1050 Q67129705-C2F29E24-26B0-4E93-A41C-5FCAB4B6EBE1 @default.
- Q67129705 P1132 Q67129705-4EBD2316-64BD-496E-868C-8FDF70FBD29B @default.
- Q67129705 P1476 Q67129705-D06C20C5-6E11-41D2-BECB-52C81F1E2AB1 @default.
- Q67129705 P17 Q67129705-0DA15C56-06C1-47E1-829D-B7EEE69C93E1 @default.
- Q67129705 P17 Q67129705-13A6CDA2-1CE9-4BC2-8A5B-922547925BC1 @default.
- Q67129705 P17 Q67129705-528B89F5-A620-47CC-AFC2-2D130D4B635D @default.
- Q67129705 P17 Q67129705-586309BF-B2DC-4D72-BCD2-29BEC38C2592 @default.
- Q67129705 P17 Q67129705-5CB55736-5067-4EDD-AB60-CB5FDC36B71B @default.
- Q67129705 P17 Q67129705-6C4D557A-DB34-41D1-A9B3-76C1248F606C @default.
- Q67129705 P17 Q67129705-8C5F3317-609F-4D72-A5A4-BEA055DF9299 @default.
- Q67129705 P17 Q67129705-C000747D-941C-4C45-8363-8C65AA3ACAA5 @default.
- Q67129705 P17 Q67129705-D0C4623E-74D5-4FEB-A966-5484B468D9D0 @default.
- Q67129705 P17 Q67129705-DF80A9F2-6560-447D-8481-AA12FA3F81B6 @default.
- Q67129705 P17 Q67129705-EAD4AB72-77AA-4773-9554-981C6602DB45 @default.
- Q67129705 P17 Q67129705-ED11A0DD-0CC5-4426-A80B-5A26F7057E6D @default.
- Q67129705 P2899 Q67129705-C2671A5A-A210-4BB3-81CB-3306F98253E2 @default.
- Q67129705 P3098 Q67129705-DB698ECF-F6D4-4CF6-AEEC-AAFF8387EECB @default.
- Q67129705 P31 Q67129705-4F23CA2F-D95C-45CC-A185-B87E47C5A0EE @default.
- Q67129705 P580 Q67129705-1E5200F6-BC68-4179-9BC4-5B68E000B878 @default.
- Q67129705 P582 Q67129705-5EEB87F8-9977-4303-8D24-8C2483EF7BAE @default.
- Q67129705 P6099 Q67129705-F45BAF27-575B-4717-BC1F-71A74F91C763 @default.
- Q67129705 P8363 Q67129705-8262F9EA-C266-4397-9A0D-813121251BE7 @default.
- Q67129705 P1050 Q178194 @default.
- Q67129705 P1132 "+510" @default.
- Q67129705 P1476 "A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation" @default.
- Q67129705 P17 Q142 @default.
- Q67129705 P17 Q145 @default.
- Q67129705 P17 Q16 @default.
- Q67129705 P17 Q183 @default.
- Q67129705 P17 Q27 @default.
- Q67129705 P17 Q29 @default.
- Q67129705 P17 Q30 @default.
- Q67129705 P17 Q34 @default.
- Q67129705 P17 Q35 @default.
- Q67129705 P17 Q38 @default.
- Q67129705 P17 Q39 @default.
- Q67129705 P17 Q55 @default.
- Q67129705 P2899 "+12" @default.
- Q67129705 P3098 "NCT02347657" @default.
- Q67129705 P31 Q30612 @default.
- Q67129705 P580 "2015-01-01T00:00:00Z" @default.
- Q67129705 P582 "2017-01-20T00:00:00Z" @default.
- Q67129705 P6099 Q42824827 @default.
- Q67129705 P8363 Q78089383 @default.